As a result of a longer life expectancy and a change in UV exposure, physicians will be facing a growing number of elderly patients with keratinocyte cancer (KC) in fair-skinned populations. The purpose of this study is to better characterize KC surgery in patients over 80 years and older with different comorbid conditions and to investigate the incidence of complications associated with KC surgery. A retrospective monocentric study of patients aged 80 and older, having surgery for KC in University Hospital of Zurich between January 1, 2022, and December 31, 2022, was conducted. Demographics, comorbidities, current medication, treatment type, tumor characteristics, surgical defect size, repair type and complications within 6 months after surgery were analyzed.
Study Type
OBSERVATIONAL
Enrollment
345
University Hospital Zurich, Dermatology Clinic
Zurich, Canton of Zurich, Switzerland
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland
Incidence of complications associated with KC surgery in individuals aged 80 years and older
Time frame: From January 1, 2022, to December 31, 2022
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.